Area of research
Immunology · Oncology
Research interest
Research interests include interferon and immune responses, Cancer Immunotherapy and Biomarkers, Immune cells in cancer, and Chemokine receptors and signaling.
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy
Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity
All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages
RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Author Correction: Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
lncRNA MIR4435‑2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF‑β1
Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy
STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non–small Cell Lung Cancers
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers
Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome
14q32-encoded microRNAs mediate an oligometastatic phenotype
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation
The inhibitory role of Mir-29 in growth of breast cancer cells